SCHEMBL31508323

SCHEMBL31508323

C[C@]12CC[C@@H]3c4ccc(OCCCN)cc4CC[C@H]3[C@@H]1CC[C@@H]2O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.74
LMNA P02545 5/20 0.74
ALDH1A1 P00352 2/20 0.72
MAPT P10636 2/20 0.72
CYP2C9 P11712 2/20 0.72
CYP2C19 P33261 2/20 0.72
STS P08842 2/20 0.70
ESR1 P03372 5/20 0.68
SMN1; SMN2 Q16637 3/20 0.68
PGR P06401 2/20 0.68
AR P10275 2/20 0.68
SLC6A3 Q01959 2/20 0.68
ADORA3 P0DMS8 2/20 0.68
ATM Q13315 2/20 0.68
ABCC1 P33527 1/20 0.68
ABCC4 O15439 1/20 0.68
CHRM1 P11229 1/20 0.68
TBXA2R P21731 1/20 0.68
ADRA1A P35348 1/20 0.68
OPRM1 P35372 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31508415 1.00 HSD17B10 (0.74) HSD17B10LMNAALDH1A1MAPTCYP2C9
SCHEMBL31508553 1.00 HSD17B10 (0.74) HSD17B10LMNAALDH1A1MAPTCYP2C9
SCHEMBL3825574 1.00 HSD17B10 (0.74) HSD17B10LMNAALDH1A1MAPTCYP2C9
SCHEMBL31508268 1.00 HSD17B10 (0.74) HSD17B10LMNAALDH1A1MAPTCYP2C9
SCHEMBL31508468 1.00 HSD17B10 (0.74) HSD17B10LMNAALDH1A1MAPTCYP2C9
SCHEMBL18541855 0.92 HSD17B10 (0.77) HSD17B10LMNAALDH1A1MAPTCYP2C9
SCHEMBL7533892 0.92 HSD17B10 (0.77) HSD17B10LMNAALDH1A1MAPTCYP2C9
SCHEMBL18487958 0.92 HSD17B10 (0.77) HSD17B10LMNAALDH1A1MAPTCYP2C9
SCHEMBL18687706 0.92 HSD17B10 (0.77) HSD17B10LMNAALDH1A1MAPTCYP2C9
SCHEMBL5438982 0.92 HSD17B10 (0.77) HSD17B10LMNAALDH1A1MAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025097061-A1 ApoB DEGRADING COMPOUNDS AND USES THEREOF AVILAR THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed